Product logins

Find logins to all Clarivate products below.


chevron_left

Six emerging U.S medical cost and access drivers to watch in 2025-2026

The passage of the One Big Beautiful Bill Act, which sharply cuts Medicaid and jettisons large portions of both the Affordable Care Act and the Inflation Reduction Act, portends seismic changes to the American healthcare system.

In this report, Clarivate market access experts identify six key trends in the fast-changing and unpredictable U.S. market access landscape and the potential implications for patients, payers, medical institutions and drug and device innovators going forward.

Related insights

The latest news, technologies, and resources from our team.

Understand key players in the regulatory space
Drugs to Watch: Market Access in Focus- Eylea® HD Drugs to Watch: Market Access in Focus- Eylea® HD
Drugs to Watch: Market Access in Focus- Eylea® HD
Global regulatory approaches to post-approval changes in biotherapeutic products
chevron_left
chevron_right